230 related articles for article (PubMed ID: 25041375)
1. Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth?
Gensure RC
Exp Dermatol; 2014 Dec; 23(12):865-7. PubMed ID: 25041375
[TBL] [Abstract][Full Text] [Related]
2. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
Peters EM; Foitzik K; Paus R; Ray S; Holick MF
J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone hormone-related protein and the PTH receptor regulate angiogenesis of the skin.
Diamond AG; Gonterman RM; Anderson AL; Menon K; Offutt CD; Weaver CH; Philbrick WM; Foley J
J Invest Dermatol; 2006 Sep; 126(9):2127-34. PubMed ID: 16675960
[TBL] [Abstract][Full Text] [Related]
4. The effect of parathyroid hormones on hair follicle physiology: implications for treatment of chemotherapy-induced alopecia.
Skrok A; Bednarczuk T; Skwarek A; Popow M; Rudnicka L; Olszewska M
Skin Pharmacol Physiol; 2015; 28(4):213-225. PubMed ID: 25721772
[TBL] [Abstract][Full Text] [Related]
5. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
[TBL] [Abstract][Full Text] [Related]
6. Control of hair growth with parathyroid hormone (7-34).
Schilli MB; Ray S; Paus R; Obi-Tabot E; Holick MF
J Invest Dermatol; 1997 Jun; 108(6):928-32. PubMed ID: 9182824
[TBL] [Abstract][Full Text] [Related]
7. Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain.
Katikaneni R; Gulati R; Suh D; Sakon J; Seymour A; Ponnapakkam T; Gensure R
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S61-2. PubMed ID: 24326563
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
9. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
10. Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: evidence for regulation at the anagen to catagen transition.
Cho YM; Woodard GL; Dunbar M; Gocken T; Jimènez JA; Foley J
J Invest Dermatol; 2003 May; 120(5):715-27. PubMed ID: 12713572
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf 1 promotes regression of hair follicles.
Kwack MH; Kim MK; Kim JC; Sung YK
J Invest Dermatol; 2012 Jun; 132(6):1554-60. PubMed ID: 22358062
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.
Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C
Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134
[TBL] [Abstract][Full Text] [Related]
13. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
Ohnemus U; Unalan M; Handjiski B; Paus R
J Invest Dermatol; 2004 Jan; 122(1):7-13. PubMed ID: 14962083
[TBL] [Abstract][Full Text] [Related]
14. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
15. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
[TBL] [Abstract][Full Text] [Related]
16. Roles of GasderminA3 in Catagen-Telogen Transition During Hair Cycling.
Bai X; Lei M; Shi J; Yu Y; Qiu W; Lai X; Liu Y; Yang T; Yang L; Widelitz RB; Chuong CM; Lian X
J Invest Dermatol; 2015 Sep; 135(9):2162-2172. PubMed ID: 25860385
[TBL] [Abstract][Full Text] [Related]
17. Hair cycle control by leptin as a new anagen inducer.
Sumikawa Y; Inui S; Nakajima T; Itami S
Exp Dermatol; 2014 Jan; 23(1):27-32. PubMed ID: 24237265
[TBL] [Abstract][Full Text] [Related]
18. Effect of mycophenolic acid on proliferation of dermal papilla cells and induction of anagen hair follicles.
Jeong KH; Joo HJ; Kim JE; Park YM; Kang H
Clin Exp Dermatol; 2015 Dec; 40(8):894-902. PubMed ID: 25808346
[TBL] [Abstract][Full Text] [Related]
19. Roxithromycin antagonizes catagen induction in murine and human hair follicles: implication of topical roxithromycin as hair restoration reagent.
Ito T; Fukamizu H; Ito N; Seo N; Yagi H; Takigawa M; Hashizume H
Arch Dermatol Res; 2009 Jun; 301(5):347-55. PubMed ID: 18820941
[TBL] [Abstract][Full Text] [Related]
20. Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.
Katikaneni R; Ponnapakkam T; Suda H; Miyata S; Sakon J; Matsushita O; Gensure RC
Int J Cancer; 2012 Sep; 131(5):E813-21. PubMed ID: 22130912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
